ANI Pharmaceuticals ANIP
$ 53.14
-2.06%
Quarterly report 2024-Q3
added 11-08-2024
Country |
USA |
IPO year |
- |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Arthur Przybyl |
Employees in the company |
338 |
Shares |
18 M |
Market Cap[1] |
$ 957 M |
EBITDA (LTM) |
$ 75.3 M |
P/E (LTM) |
-95.12 |
P/S (LTM) |
2.08 |
EPS (LTM) |
-0.65 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.